These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 7491498

  • 1. Definition of two angiogenic pathways by distinct alpha v integrins.
    Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA.
    Science; 1995 Dec 01; 270(5241):1500-2. PubMed ID: 7491498
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
    Kumar CC, Malkowski M, Yin Z, Tanghetti E, Yaremko B, Nechuta T, Varner J, Liu M, Smith EM, Neustadt B, Presta M, Armstrong L.
    Cancer Res; 2001 Mar 01; 61(5):2232-8. PubMed ID: 11280792
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
    Barillari G, Sgadari C, Palladino C, Gendelman R, Caputo A, Morris CB, Nair BC, Markham P, Nel A, Stürzl M, Ensoli B.
    J Immunol; 1999 Aug 15; 163(4):1929-35. PubMed ID: 10438928
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.
    Nisato RE, Tille JC, Jonczyk A, Goodman SL, Pepper MS.
    Angiogenesis; 2003 Aug 15; 6(2):105-19. PubMed ID: 14739617
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of growth factors on expression of integrin subtypes in microvascular endothelial cells isolated from bovine retinas.
    Enaida H, Ito T, Oshima Y, Sakamoto T, Yago K, Kato K, Kochi H.
    Fukushima J Med Sci; 1998 Jun 15; 44(1):43-52. PubMed ID: 9775530
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability.
    Issbrücker K, Marti HH, Hippenstiel S, Springmann G, Voswinckel R, Gaumann A, Breier G, Drexler HC, Suttorp N, Clauss M.
    FASEB J; 2003 Feb 15; 17(2):262-4. PubMed ID: 12490545
    [Abstract] [Full Text] [Related]

  • 18. Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin.
    Klemke RL, Yebra M, Bayna EM, Cheresh DA.
    J Cell Biol; 1994 Nov 15; 127(3):859-66. PubMed ID: 7525598
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells.
    Mechtcheriakova D, Schabbauer G, Lucerna M, Clauss M, De Martin R, Binder BR, Hofer E.
    FASEB J; 2001 Jan 15; 15(1):230-242. PubMed ID: 11149911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.